NDC 16714-440

DEBLITANE

Norethindrone

DEBLITANE is a Kit in the Human Prescription Drug category. It is labeled and distributed by Northstar Rx Llc. The primary component is .

Product ID16714-440_d9815244-f1c6-45bd-8f39-47ed32428fc9
NDC16714-440
Product TypeHuman Prescription Drug
Proprietary NameDEBLITANE
Generic NameNorethindrone
Dosage FormKit
Marketing Start Date2013-09-13
Marketing CategoryANDA / ANDA
Application NumberANDA202014
Labeler NameNorthstar Rx LLC
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 16714-440-01

1 BLISTER PACK in 1 PACKET (16714-440-01) > 1 KIT in 1 BLISTER PACK
Marketing Start Date2013-09-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 16714-440-04 [16714044004]

DEBLITANE KIT
Marketing CategoryANDA
Application NumberANDA202014
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-09-13

NDC 16714-440-03 [16714044003]

DEBLITANE KIT
Marketing CategoryANDA
Application NumberANDA202014
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-01

NDC 16714-440-02 [16714044002]

DEBLITANE KIT
Marketing CategoryANDA
Application NumberANDA202014
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-01

NDC 16714-440-01 [16714044001]

DEBLITANE KIT
Marketing CategoryANDA
Application NumberANDA202014
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-09-13

Drug Details

OpenFDA Data

SPL SET ID:e75367ff-78af-4bd2-a99d-d291cb1d21eb
Manufacturer
RxNorm Concept Unique ID - RxCUI
  • 198042
  • 1539953
  • 748961

    • Medicade Reported Pricing

    16714044004 DEBLITANE 0.35 MG TABLET

    Pricing Unit: EA | Drug Type:

    16714044001 DEBLITANE 0.35 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "DEBLITANE" or generic name "Norethindrone"

    NDCBrand NameGeneric Name
    16714-440DEBLITANENorethindrone
    51862-102CamilaNorethindrone
    51862-884CAMILANORETHINDRONE
    0555-0344ErrinNorethindrone
    51862-100ErrinNorethindrone
    51862-886ERRINNORETHINDRONE
    57297-877Jencyclanorethindrone
    52544-892JolivetteNORETHINDRONE
    50102-300LyleqNORETHINDRONE
    53002-1793LyleqNORETHINDRONE
    50102-100LYZAnorethindrone
    53002-1687LYZAnorethindrone
    52544-629Nora BENorethindrone
    0378-7272NorethindroneNorethindrone
    0378-7292NORETHINDRONEnorethindrone
    50090-2150NorethindroneNorethindrone
    50090-6161NORETHINDRONENORETHINDRONE
    57297-876NORETHINDRONENORETHINDRONE
    63187-748NorethindroneNorethindrone
    42291-650Norethindrone AcetateNorethindrone
    50268-602Norethindrone AcetateNorethindrone
    50090-3235Norlydanorethindrone
    51660-127NORLYROCnorethindrone
    50458-194Ortho MicronorNORETHINDRONE
    16714-441SHAROBELNorethindrone
    50102-200TulanaNORETHINDRONE
    53002-2687TulanaNORETHINDRONE

    Trademark Results [DEBLITANE]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DEBLITANE
    DEBLITANE
    85927838 4676036 Live/Registered
    Novast Laboratories, Inc.
    2013-05-09
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.